We are live on ! Find out more
MBE

Michael B. Elefante Portfolio holdings

AUM $91.5M Turnover 27.89%
1-Year Est. Return 13.24%
This Fund
S&P 500
This Quarter Est. Return
+5.5%
1 Year Est. Return
+13.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$91.5M
AUM Growth
-$140M
Cap. Flow
-$147M
Cap. Flow %
-161.07%
Top 10 Hldgs %
32.18%
Holding
147
New
3
Increased
5
Reduced
92
Closed
38
Avg Time Held
1.2 years
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
1.2 years

Top Buys

Rank Stock Value
1
CDK
CDK Global, Inc.
CDK
+$327K
2
COL
Rockwell Collins
COL
+$213K
3
CBRL icon
Cracker Barrel
CBRL
+$19.9K
4
SRCL icon
Stericycle Inc
SRCL
+$18.3K
5
FRC
First Republic Bank
FRC
+$11.6K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$6.51M
2
CNI icon
Canadian National Railway
CNI
+$5.43M
3
NVS icon
Novartis
NVS
+$5.24M
4
MA icon
Mastercard
MA
+$5.23M
5
JNJ icon
Johnson & Johnson
JNJ
+$5.15M

Sector Composition

Rank Sector Weight
1 Technology 24.99%
2 Healthcare 21.06%
3 Industrials 19.34%
4 Energy 10.11%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ANSS icon
51
DELISTED
Ansys
ANSS
$383K 0.42%
4,672
+55
+1% +$4.36K
2013 Q2
6 quarters
COST icon
52
Costco
COST
$435B
$379K 0.41%
2,677
-1,196
-31% -$163K
2013 Q2
6 quarters
CDK
53
DELISTED
CDK Global, Inc.
CDK
$375K 0.41%
+9,235
New +$327K
2014 Q4
0 quarters
IONS icon
54
Ionis Pharmaceuticals
IONS
$7.1B
$370K 0.4%
6,005
-14,350
-70% -$708K
2014 Q2
2 quarters
BRK.B icon
55
Berkshire Hathaway Class B
BRK.B
$1.13T
$368K 0.4%
2,450
-2,950
-55% -$426K
2013 Q2
6 quarters
CTSH icon
56
Cognizant
CTSH
$28.1B
$347K 0.38%
6,590
-25
-0.4% -$1.25K
2013 Q2
6 quarters
NEOG icon
57
Neogen
NEOG
$2.65B
$332K 0.36%
17,829
-67
-0.4% -$1.1K
2013 Q2
6 quarters
LECO icon
58
Lincoln Electric
LECO
$14.1B
$327K 0.36%
4,736
-65
-1% -$4.54K
2013 Q2
6 quarters
GOOG icon
59
Alphabet (Google) Class C
GOOG
$4.2T
$321K 0.35%
12,193
-10,028
-45% -$269K
2014 Q2
2 quarters
PCP
60
DELISTED
PRECISION CASTPARTS CORP
PCP
$320K 0.35%
1,329
-35
-3% -$8.08K
2013 Q2
6 quarters
TROW icon
61
T. Rowe Price
TROW
$21.3B
$314K 0.34%
3,655
-10
-0.3% -$815
2013 Q2
6 quarters
HES icon
62
DELISTED
Hess
HES
$295K 0.32%
4,000
– –
2013 Q2
6 quarters
PFE icon
63
Pfizer
PFE
$166B
$269K 0.29%
9,085
-343
-4% -$9.84K
2013 Q2
6 quarters
NTRS icon
64
Northern Trust
NTRS
$29.8B
$263K 0.29%
3,905
-15
-0.4% -$998
2013 Q2
6 quarters
AKAM icon
65
Akamai
AKAM
$13.2B
$262K 0.29%
4,160
-15
-0.4% -$904
2014 Q1
3 quarters
DE icon
66
Deere & Co
DE
$175B
$256K 0.28%
2,900
-1,700
-37% -$147K
2013 Q2
6 quarters
NEE icon
67
NextEra Energy
NEE
$163B
$248K 0.27%
9,320
-40
-0.4% -$1.01K
2013 Q2
6 quarters
NBL
68
DELISTED
Noble Energy, Inc.
NBL
$248K 0.27%
5,228
-10
-0.2% -$542
2013 Q2
6 quarters
PAYX icon
69
Paychex
PAYX
$38.6B
$239K 0.26%
5,185
-15
-0.3% -$693
2013 Q3
5 quarters
COL
70
DELISTED
Rockwell Collins
COL
$218K 0.24%
+2,590
New +$213K
2014 Q4
0 quarters
FFIV icon
71
F5
FFIV
$25.9B
$217K 0.24%
1,663
-5
-0.3% -$623
2014 Q1
3 quarters
T icon
72
AT&T
T
$158B
$213K 0.23%
8,399
-14
-0.2% -$363
2013 Q2
6 quarters
JPM icon
73
JPMorgan Chase
JPM
$890B
$210K 0.23%
3,359
-3,105
-48% -$187K
2013 Q2
6 quarters
PSX icon
74
Phillips 66
PSX
$119B
$197K 0.22%
2,750
– –
2013 Q4
4 quarters
HAR
75
DELISTED
Harman International Industries
HAR
$196K 0.21%
1,840
-10
-0.5% -$1.03K
2014 Q1
3 quarters
1 2
3
4 5

Similar funds

AEPI
AH Equity Partners II Menlo Park, California $91.5M AUM
CC
Columbia Capital Fullerton, California $91.6M AUM 27.93% 1-Year Est. Return
TM
TigerShark Management New York $98.9M AUM 11.4% 1-Year Est. Return
VNB
Valley National Bancorp New York $81.9M AUM 5.36% 1-Year Est. Return
ECP
Empirical Capital Partners Ringgold, Georgia $101M AUM
WIL
Winifred I. Li $106M AUM 11.93% 1-Year Est. Return
RCM
Raptor Capital Management Boston, Massachusetts $73.2M AUM 23.77% 1-Year Est. Return
ZTNA
Zions Trust National Association Salt Lake City, Utah $69.4M AUM 2.73% 1-Year Est. Return

Michael B. Elefante's Q4 2014 Portfolio in Review

As of Q4 2014, Michael B. Elefante held 147 positions worth $91.5M, down 61% from $232M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Michael B. Elefante withdrew a net $147M in Q4 2014, closing 38 positions and reducing 92 holdings. Its most notable exit was Labcorp, an estimated $1.76M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Michael B. Elefante opened a new position in CDK Global, Inc. worth $375K.

  • Michael B. Elefante's largest Q4 2014 buy was CDK Global, Inc.: 9,235 shares worth $375K.
  • Michael B. Elefante added most to Stericycle Inc in Q4 2014, an estimated $18.3K increase.
  • Michael B. Elefante's biggest Q4 2014 reduction was CVS Health, cutting an estimated $6.51M.
  • Michael B. Elefante fully exited Labcorp in Q4 2014, selling an estimated $1.76M.
  • Michael B. Elefante's ten largest holdings make up 32% of its $91.5M portfolio in Q4 2014.
  • Michael B. Elefante opened 3 new positions and closed 38 in Q4 2014.
  • Michael B. Elefante's portfolio value fell 61% quarter-over-quarter to $91.5M.

Based on Michael B. Elefante's 13F filing for Q4 2014, filed 13 Feb 2015.